PT845988E - Novas isoquinolinas fundidas como ligandos do receptor da dopamina - Google Patents

Novas isoquinolinas fundidas como ligandos do receptor da dopamina

Info

Publication number
PT845988E
PT845988E PT96928941T PT96928941T PT845988E PT 845988 E PT845988 E PT 845988E PT 96928941 T PT96928941 T PT 96928941T PT 96928941 T PT96928941 T PT 96928941T PT 845988 E PT845988 E PT 845988E
Authority
PT
Portugal
Prior art keywords
receptor ligands
diphamine
new
compounds
dopamine
Prior art date
Application number
PT96928941T
Other languages
English (en)
Inventor
David E Nichols
Richard Mailman
Debasis Ghosh
Original Assignee
Univ North Carolina
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina, Purdue Research Foundation filed Critical Univ North Carolina
Publication of PT845988E publication Critical patent/PT845988E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
PT96928941T 1995-08-18 1996-08-16 Novas isoquinolinas fundidas como ligandos do receptor da dopamina PT845988E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US251995P 1995-08-18 1995-08-18

Publications (1)

Publication Number Publication Date
PT845988E true PT845988E (pt) 2002-05-31

Family

ID=21701148

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96928941T PT845988E (pt) 1995-08-18 1996-08-16 Novas isoquinolinas fundidas como ligandos do receptor da dopamina

Country Status (18)

Country Link
US (2) US5959110A (pt)
EP (1) EP0845988B1 (pt)
JP (1) JP2000505046A (pt)
CN (1) CN1199338A (pt)
AT (1) ATE209915T1 (pt)
AU (1) AU700688B2 (pt)
BR (1) BR9610323A (pt)
CA (1) CA2227585A1 (pt)
DE (1) DE69617700T2 (pt)
DK (1) DK0845988T3 (pt)
ES (1) ES2169257T3 (pt)
IL (1) IL122974A (pt)
MX (1) MX9801179A (pt)
NO (1) NO308658B1 (pt)
NZ (1) NZ316312A (pt)
PT (1) PT845988E (pt)
RU (1) RU2177001C2 (pt)
WO (1) WO1997006799A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL122974A (en) * 1995-08-18 2000-11-21 Purdue Research Foundation Optionally substituted tetrahydro-1H-naph[1,2,3-de]isoquinoline and pharmaceutical compositions containing them
AU8824201A (en) * 2000-08-11 2002-02-25 Bristol Myers Squibb Co Process for the preparation of dinapsoline
MXPA03006265A (es) * 2001-01-16 2004-06-25 Purdue Research Foundation Metodo de tratamiento de disfuncion relacionada con dopamina mediante administracion de un agonista de receptor de dopamina d1 completo, sin generacion de tolerancia.
US7091212B2 (en) 2001-08-10 2006-08-15 Purdue Research Foundation Chiral dinapsoline
DE60323339D1 (de) * 2002-02-15 2008-10-16 Darpharma Inc Monoester und asymmetrisch substituierte diester prodrugs der dopamin-d1-rezeptor-agonisten
JP2004190007A (ja) * 2002-11-27 2004-07-08 Konica Minolta Holdings Inc 色素およびインクジェット記録液
WO2005029077A1 (en) * 2003-09-24 2005-03-31 Biacore Ab Method and system for molecular interaction analysis
EP2010541A2 (en) * 2006-02-21 2009-01-07 Purdue Research Foundation Trans-fused chromenoisoquinolines, synthesis and methods for use
PL2317852T3 (pl) * 2008-07-16 2015-05-29 Richter Gedeon Nyrt Preparaty farmaceutyczne zawierające ligandy receptora dopaminy
EP2421862B1 (en) 2009-04-21 2014-06-11 Purdue Research Foundation Octahydrobenzoisoquinoline modulators of dopamine receptors and uses therefor
CN110068645B (zh) * 2019-04-03 2021-09-03 上海药明奥测医疗科技有限公司 液质联用检测尿液中环磷酸腺苷的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346090A (en) * 1977-07-21 1982-08-24 Ayerst, Mckenna & Harrison Ltd. 13-Chloro-benzocycloheptapyridoisoquinolines and use as neuroleptics
US5047536A (en) * 1989-03-17 1991-09-10 Purdue Research Foundation Hexahydrobenzo(A)phenanthridine compounds
IE912999A1 (en) * 1990-09-07 1992-03-11 Abbott Lab Phenanthridine compounds
DE69334206D1 (de) * 1992-05-26 2008-04-03 Purdue Research Foundation Substituierte hexahydrobenzo(a) phenanthridine
IL122974A (en) * 1995-08-18 2000-11-21 Purdue Research Foundation Optionally substituted tetrahydro-1H-naph[1,2,3-de]isoquinoline and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
US6194423B1 (en) 2001-02-27
NO980688L (no) 1998-02-18
RU2177001C2 (ru) 2001-12-20
BR9610323A (pt) 1999-12-21
NO308658B1 (no) 2000-10-09
DE69617700T2 (de) 2002-07-18
IL122974A (en) 2000-11-21
ES2169257T3 (es) 2002-07-01
AU6851396A (en) 1997-03-12
NO980688D0 (no) 1998-02-18
EP0845988B1 (en) 2001-12-05
JP2000505046A (ja) 2000-04-25
EP0845988A1 (en) 1998-06-10
CN1199338A (zh) 1998-11-18
AU700688B2 (en) 1999-01-14
ATE209915T1 (de) 2001-12-15
WO1997006799A1 (en) 1997-02-27
IL122974A0 (en) 1998-08-16
DK0845988T3 (da) 2002-04-02
MX9801179A (es) 1998-04-30
EP0845988A4 (en) 1998-11-11
DE69617700D1 (de) 2002-01-17
CA2227585A1 (en) 1997-02-27
NZ316312A (en) 1999-06-29
US5959110A (en) 1999-09-28

Similar Documents

Publication Publication Date Title
RO115522B1 (ro) Derivaţi de indolină, procedee pentru prepararea acestora, compoziţii farmaceutice care îi conţin şi metodă de tratament
DE60022050T2 (de) Metabotrope glutamatrezeptorantagonisten zur behandlung von krankheiten des zentralen nervensystems
PT912184E (pt) Utilizacao de um derivado de k-252a para o tratamento de doencas do sietma nervoso central ou periferico e sobre-producao de citoquina
PT845988E (pt) Novas isoquinolinas fundidas como ligandos do receptor da dopamina
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
PL320822A1 (en) Sulphonamidic compounds as therapeutic agents for treatment of central nervous system, method of obtaining novel sulphonamidic compounds and drugs containing such compounds
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
ES2114471A1 (es) Nuevos compuestos de paroxetina y procedimiento para su preparacion.
ATE416164T1 (de) Pharmazeutische zusammenstellungen zur prävention und behandlung von zns-erkrankungen
DK0869808T3 (da) Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
ATE219068T1 (de) Naphtylamides als zentralnervensystemmittel
ATE247639T1 (de) Arylsubstituierte cyclische amine als selektive dopamin-d3-liganden
NO20015413D0 (no) Anvendelse av dopamin-D3-reseptor-ligander for fremstilling av medikamenter for behandling av nyrefunksjonsforstyrrelser
UA72948C2 (uk) Заміщені похідні фенілпіперазину, фармацевтична композиція та спосіб лікування афективних або неврологічних захворювань і розладів
DE60004671D1 (de) Neue piperazinylalkylthiopyrimidine derivate, diese enthaltende pharmazeutische zusammenstellungen und verfahren zu deren herstellung
BR0011534A (pt) Alquilaminas aril substituìdas capazes de ativação de receptores colinérgicos nicotìnicos
YU42098A (sh) Upotreba olanzapina
ATE214375T1 (de) Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung
DE69736180D1 (de) Behandlung von manischen erkrankungen
ATE369354T1 (de) Isochinolin-aroylpyrrole für die behandlung von krankheiten des zentralnervensystems
ATE198984T1 (de) Verwendung von phenoxypyridinderivaten zur behandlung der durch stoerungen des dopaminsystems verursachten erkrankungen